Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Patient history is key in diagnosing hair loss types.

Trichoscopy is crucial for diagnosing alopecia areata by identifying specific hair features.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Koilonychia in alopecia areata can improve with oral corticosteroids.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

Lupus and frontal fibrosing alopecia may share a common cause.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

A 16-year-old boy had pernicious anemia, autoimmune hemolytic anemia, and later developed alopecia areata.

Alopecia areata patients may have hearing loss linked to the condition's severity and duration.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Alopecia areata patients often have low vitamin D levels, suggesting they might benefit from vitamin D supplements.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.